Fifty Years of Research on Schizophrenia: The Ascendance of the Glutamatergic Synapse
- PMID: 33256439
- PMCID: PMC8011846
- DOI: 10.1176/appi.ajp.2020.20101481
Fifty Years of Research on Schizophrenia: The Ascendance of the Glutamatergic Synapse
Keywords: Antipsychotics; Genetics/Genomics; History of Psychiatry; Neuropathology; Schizophrenia Spectrum and Other Psychotic Disorders.
Figures

Similar articles
-
Glutamatergic animal models of schizophrenia.Curr Pharm Des. 2012;18(12):1593-604. doi: 10.2174/138161212799958576. Curr Pharm Des. 2012. PMID: 22280432 Review.
-
Celebrating twenty years of schizophrenia research.Schizophr Res. 2008 Mar;100(1-3):1-3. doi: 10.1016/j.schres.2008.01.021. Epub 2008 Feb 13. Schizophr Res. 2008. PMID: 18276117 No abstract available.
-
Significance of dysfunctional glutamatergic transmission for the development of psychotic symptoms.Pol J Pharmacol. 2003 Mar-Apr;55(2):133-54. Pol J Pharmacol. 2003. PMID: 12926541 Review.
-
Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia.Ann N Y Acad Sci. 2003 Nov;1003:75-93. doi: 10.1196/annals.1300.005. Ann N Y Acad Sci. 2003. PMID: 14684436 Review.
-
Editorial: New treatment strategies in schizophrenia beyond dopamine: glutamatergic neurotransmission and more.Curr Pharm Biotechnol. 2012 Jun;13(8):1474-5. doi: 10.2174/138920112800784871. Curr Pharm Biotechnol. 2012. PMID: 22283749 No abstract available.
Cited by
-
A Critical Reappraisal of Haloperidol for Delirium Management in the Intensive Care Unit: Perspective from Psychiatry.J Clin Med. 2025 Jan 11;14(2):438. doi: 10.3390/jcm14020438. J Clin Med. 2025. PMID: 39860443 Free PMC article. Review.
-
Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D3 Receptors in the Brain in vivo.Front Psychiatry. 2022 Mar 24;13:785592. doi: 10.3389/fpsyt.2022.785592. eCollection 2022. Front Psychiatry. 2022. PMID: 35401257 Free PMC article. Review.
-
Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study.Mol Psychiatry. 2024 Nov;29(11):3669-3679. doi: 10.1038/s41380-024-02631-4. Epub 2024 Jun 7. Mol Psychiatry. 2024. PMID: 38849515 Free PMC article.
-
Molecular Rhythmicity in Glia: Importance for Brain Health and Relevance to Psychiatric Disease.Biol Psychiatry. 2024 Dec 15;96(12):909-918. doi: 10.1016/j.biopsych.2024.05.007. Epub 2024 May 10. Biol Psychiatry. 2024. PMID: 38735357 Free PMC article. Review.
-
Novel Compounds in the Treatment of Schizophrenia-A Selective Review.Brain Sci. 2023 Aug 11;13(8):1193. doi: 10.3390/brainsci13081193. Brain Sci. 2023. PMID: 37626549 Free PMC article. Review.
References
-
- Snyder SH: The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. Am J Psychiatry 1976; 133:197–202 - PubMed
-
- Bird ED, Spokes EG, Barnes J, et al.: Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses. Lancet 1977; 2:1157–1158 - PubMed
-
- Johnstone EC, Crow TJ, Frith CD, et al.: Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976; 2:924–926 - PubMed
-
- Axelrod J: Noradrenaline: fate and control of its biosynthesis. Science 1971; 173:598–606 - PubMed
-
- Schildkraut JJ: The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 1965; 122:509–522 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical